Browse > Article

Whitening Efficacy of Water Soluble Royal Jelly Removed Allergenic Protein  

Han, Sang Mi (National Academy of Agricultural Science, Rural Development Administration)
Kim, Jung Min (National Academy of Agricultural Science, Rural Development Administration)
Kim, Se Gun (National Academy of Agricultural Science, Rural Development Administration)
Jang, Hye Ri (National Academy of Agricultural Science, Rural Development Administration)
Yeo, Joo Hong (National Academy of Agricultural Science, Rural Development Administration)
Hong, In Pyo (National Academy of Agricultural Science, Rural Development Administration)
Woo, Soon Ok (National Academy of Agricultural Science, Rural Development Administration)
Publication Information
Korean Journal of Pharmacognosy / v.45, no.3, 2014 , pp. 262-267 More about this Journal
Abstract
Royal jelly composes of many components, especially protein. Protein is a major factor which cause allergy. We focused on water soluble royal jelly (WSRJ) that was removed allergy - inducing protein. 10-hyroxy-2-decenoic acid content of WSRJ is 2.42 g/100 g, which is double compared to that of lypophilized RJ. To further access WSRJ as a cosmetic ingredient and potential external treatment for topical use, we investigated its ability to inhibit tyrosinase activity and melanin biosynthesis on melanogenesis in B16F1 melanoma cells. We found that WSRJ increased the cell viability in B16F1 melanoma cell and WSRJ (1~10 mg/ml) inhibited melanin synthesis in with 10 nM ${\alpha}$-melanocyte-stimulating hormone (${\alpha}$-MSH) for 48 h. WSRJ inhibited direct tyrosinase activity, which decreased melanin synthesis in ${\alpha}$-MSH stimulated B16F1 melanoma cells. Thease findings suggest that WSRJ induces the down regulation of melanogenesis by inhibiting tyrosinase activation.
Keywords
Royal jelly; soluble protein; tyrosinase; melanin; B16F1;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Fujiwara, S., Imai, J., Fujiwara, M., Yaeshima, T., Kawashima, T. and Kobayashi, K. (1990) A potent antibacterial protein in royal jelly. Purification and determination of the primary structure of royalisin. J. Biol. Chem. 265: 11333-11337.
2 Nagai, T. and Inoue, R. (2004) Preparation and the functional properties of water extract and alkaline extract of royal jelly. Food Chem. 84: 181-186.   DOI   ScienceOn
3 Santos, C. C. and Marcucci, M. C. (2007) Quantitative determination of trans-10-Hydroxy-2-Decenoic Acid (10-HDA) in Brazilian royal jelly and commercial products containing royal jelly. J. Apicult. Res. 46: 149-153.   DOI
4 Sabatini, A. G., Marcazzan, G. L., Caboni, M. F., Bogdanov, S. and Almeida-Muradian, L. B. (2009) Quality and satndardisation of royal jelly. J. ApiProd. ApiMed. Sci. 1: 1-6.   DOI
5 Krell, R. (1996) Value-added products from beekeeping. 409. FAO Food and Agriculture Organization of the United Nations Rome.
6 Bincoletto, C., Eberlin, S., Figueiredo, C. A., Luengo, M. B. and Queiroz, M. L. (2005) Effects produced by royal jelly on haematopoiesis: relation with host resistance against Ehrlich ascites tumour challenge. Int. Immunopharmacol. 5: 679-688.   DOI   ScienceOn
7 Nakaya, M., Onda, H., Sasaki, K., Yukiyoshi, A., Tachibana, H. and Yamada, K. (2007) Effect of royal jelly on bisphenol A-induced proliferation of human breast cancer cells. Biosci. Biotechnol. Biochem. 71: 253-255.   DOI   ScienceOn
8 Leung, R., Ho, A., Chan, J., Choy, D. and Lai, C. K. (1997) Royal jelly consumption and hypersensitivity in the community. Clinical & Experimental Allergy 27: 333-336.   DOI
9 Taniguchi, Y., Kohno, K., Inoue, S., Koya-Miyata, S., Okamoto, I., Arai, N., Iwaki, K., Ikeda, M. and Kurimoto, M. (2003) Oral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice. Int. Immunopharmacol. 3: 1313-1324.   DOI   ScienceOn
10 Thien, F. C., Leung, R., Plomley, R., Weiner, J. and Czarny, D. (1993) Royal jelly-induced asthma. Med. J. Aust. 159: 639.
11 Takahama, H. and Shimazu, T. (2006) Food-induced anaphylaxis caused by ingestion of royal jelly. J. Dermatol. 33: 424-426.   DOI   ScienceOn
12 Yonei, Y., Shibagaki, K., Tsukada, N., Nagasu, N., Inagaki, Y., Miyamoto, K., Suzuki, O. and Kiryu, Y. (1997) Case report: haemorrhagic colitis associated with royal jelly intake. J. Gastroenterol. Hepatol. 12: 495-499.   DOI
13 Mizutani, Y., Shibuya, Y., Takahashi, T., Tsunoda, T., Moriyama, T. and Seishima, M. (2011) Major royal jelly protein 3 as a possible allergen in royal jelly-induced anaphylaxis. J. Dermatol. 38: 1079-1081.   DOI
14 Kim, J. M., Han, S. M., Cho, M. R., Lee, K. G., Lee, M. L., Lee, M. Y., Woo, S. O., Hong, I. P., Sim, H. S. and Choi, Y. S. (2013) Characterization of water soluble royal jelly removed allergenic protein. Korean J. Apiculture 28: 19-23.
15 Han, S. M., Lee, K. G., Yeo, J. H. and Lee, M. Y. (2010) Effect of melanin inhibitory effect of royal jelly from Korea in mouse melanoma cells. Korean J. Apiculture 25: 123-128.
16 Chung, M. J., Walker, P. A., Brown, R. W. and Hogstrand, C. (2005) ZINC-mediated gene expression offers protection against H2O2-induced cytotoxicity. Toxicol. Appl. Pharmacol. 205: 225-236.
17 Guo, H., Ekusa, A., Iwai, K., Yonekura, M., Takahata, Y. and Morimatsu, F. (2008) Royal jelly peptides inhibit lipid peroxidation in vitro and in vivo. J. Nutr. Sci. Vitaminol (Tokyo) 54: 191-195.   DOI
18 Han, S. M., Lee, K. G., Yeo, J. H., Kweon, H. Y. and Woo, S. O. (2007) A simplified purificating method of bee venom. Patent.
19 Yagi, A., Kanbara, T. and Morinobu, N. (1987) Inhibition of mushroom-tyrosinase by aloe extract. Planta Med. 53: 515-517.   DOI   ScienceOn
20 Hosoi, J., Abe, E., Suda, T. and Kuroki, T. (1985) Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. Cancer Res. 45: 1474-1478.
21 Okamoto, I., Taniguchi, Y., Kunikata, T., Kohno, K., Iwaki, K., Ikeda, M. and Kurimoto, M. (2003) Major royal jelly protein 3 modulates immune responses in vitro and in vivo. Life Sci. 73: 2029-2045.   DOI   ScienceOn
22 Kohno, K., Okamoto, I., Sano, O., Arai, N., Iwaki, K., Ikeda, M. and Kurimoto, M. (2004) Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages. Biosci. Biotechnol. Biochem. 68: 138-145.   DOI   ScienceOn
23 Tokunaga, K. H., Yoshida, C., Suzuki, K. M., Maruyama, H., Futamura, Y., Araki, Y. and Mishima, S. (2004) Antihypertensive effect of peptides from royal jelly in spontaneously hypertensive rats. Biol. Pharm. Bull. 27: 189-192.   DOI   ScienceOn
24 Hearing, V. J. and Jimenez, M. (1989) Analysis of mammalian pigmentation at the molecular level. Pigment Cell Res. 2: 75-85.   DOI   ScienceOn
25 Urabe, K., Nakayama, J. and Hori, Y. (1998) Mixed epidermal and dermal hypermelanoses, in The pigmentary System: Physiology and Pathophysiology," eds. Norlund, J. J., Boissy, R. E., Hearing, V. J., King, R. A. and Ortonne, J. P. 909. Oxford University Press, New York.
26 Silici, S., Ekmekcioglu, O., Eraslan, G. and Demirtas, A. (2009) Antioxidative effect of royal jelly in cisplatin-induced testes damage. Urology 74: 545-551.   DOI   ScienceOn
27 Mallick, S., Singh, S. K., Sarkar, C., Saha, B. and Bhadra, R. (2005) Human placental lipid induces melanogenesis by increasing the expression of tyrosinase and its related proteins in vitro. Pigment Cell Res. 18: 25-33.   DOI   ScienceOn
28 Viuda-Martos, M., Ruiz-Navajas, Y., Fernandez-Lopez, J. and Perez-Alvarez, J. A. (2008) Functional properties of honey, propolis, and royal jelly. J. Food Sci. 73: R117-124.